MT2A is an early predictive biomarker of response to chemotherapy and a potential therapeutic target in osteosarcoma

por Mangelinck, Adèle, da Costa, Maria Eugénia Marques, Stefanovska, Bojana, Bawa, Olivia, Polrot, Mélanie, Gaspar, Nathalie, Fromigué, Olivia
Publicado 2019

Pickering emulsions with ethiodized oil and nanoparticles for slow release of intratumoral anti-CTLA4 immune checkpoint antibodies

por Tselikas, Lambros, de Baere, Thierry, Isoardo, Thomas, Susini, Sandrine, Ser-Le Roux, Karine, Polrot, Mélanie, Adam, Julien, Rouanne, Mathieu, Zitvogel, Laurence, Moine, Laurence, Deschamps, Fréderic, Marabelle, Aurélien
Publicado 2020